about
Assessment of timeliness, representativeness and quality of data reported to Italy's national integrated surveillance system for acute viral hepatitis (SEIEVA).Acute myeloid leukemia in patients previously diagnosed with breast cancer: experience of the GIMEMA group.Use of hierarchical models to evaluate performance of cardiac surgery centres in the Italian CABG outcome studyMethodological issues in papers on IFN therapy: time for reappraisal.Surveillance of hepatitis A virus in urban sewages and comparison with cases notified in the course of an outbreak, Italy 2013microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virusThe use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project.Biomarkers of subclinical atherosclerosis in patients with autoimmune disorders.Key Role of Sequencing to Trace Hepatitis A Viruses Circulating in Italy During a Large Multi-Country European Foodborne Outbreak in 2013.Human herpes virus-6 seroprevalence and leukaemias: a case-control study. GIMEMA (Gruppo Italiano Malattie Ematologiche dell' Adulto).Risk of hepatitis A infection following travel.Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency.Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town.Hepatitis E virus: Assessment of the epidemiological situation in humans in Europe, 2014/15.Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.Estimating the incidence, prevalence and clinical burden of hepatitis C over time in Italy.Association of intracellular pro- and anti-inflammatory cytokines in peripheral blood with the clinical or ultrasound indications for carotid endarterectomy in patients with carotid atherosclerosis.Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: A retrospective cohort study.A large prolonged outbreak of hepatitis A associated with consumption of frozen berries, Italy, 2013-14.Correlates of infection and molecular characterization of blood-borne HIV, HCV, and HBV infections in HIV-1 infected inmates in Italy: An observational cross-sectional study.Large and prolonged food-borne multistate hepatitis A outbreak in Europe associated with consumption of frozen berries, 2013 to 2014.Clinical, epidemiological and virological features of acute hepatitis B in Italy.HBV whole-genome mutation profile in HIV-1/HBV coinfected patients in a long-term follow-up study.Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study).Etiology of and risk factors for transient and persistent aminotransferase elevation in a population of virus-free blood donors: a multicentre study.HIV-HCV RNA loads and liver failure in coinfected patients with coagulopathy.Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy.Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey.Correlation of alcohol consumption with liver histological features in non-cirrhotic patients.Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign.Feasibility of vaccination in preventing secondary cases of hepatitis A virus infection.Risk factors for and incidence of acute hepatitis C after the achievement of blood supply safety in Italy: results from the national surveillance system.Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology).Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients.The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.Persistence of immunity 18-19 years after vaccination against hepatitis B in 2 cohorts of vaccinees primed as infants or as adolescents in Italy.Evaluation of the compliance with the protocol for preventing perinatal hepatitis B infection in Italy.Characteristics of hepatocellular carcinoma in Italy.Hepatitis B immunity in teenagers vaccinated as infants: an Italian 17-year follow-up study.
P50
Q30913431-C0F6DF39-9479-412F-82D6-FA198D68D132Q30985931-BF6AA5CB-D104-414E-8D81-3E7256DE8242Q33289805-FEB7C105-FFB5-4E87-8B90-24F1946885E4Q33940500-2E826F65-3D2A-4D04-8B44-898BF19AA1EAQ34006763-E8292C20-81D5-4360-8245-9EC6D15B4288Q34163429-C53C623C-92DE-4DB1-96BE-1897C1164B09Q35193749-36BA12B0-5CC4-4FF8-8998-7D413C084040Q35864204-106369B4-5C19-41B8-963D-759B563C8F9AQ35931499-B8B7FCC8-BE22-4042-BDD8-77D2A0E3BCB8Q36620309-88727934-8DBE-4899-BDC7-0048B961CE74Q38947382-415976EE-92FF-4DDC-8910-F3A0C1B1FFC9Q39409509-48AFBF8C-976A-49C6-A957-1ECFFF743257Q39542487-4A64817F-7FEF-4F24-8271-0E0C84205FFCQ39619400-D6A7F9CD-4D8D-45FA-A8AE-CD54D57DF61BQ39875653-00F1ABD9-C2F2-4BD2-992E-A94451317DA7Q39965299-9FB33379-5E2C-4946-B1E6-D2E2DF8F6EE0Q40118793-08DAF398-2B5D-4B2E-882C-34D4EC404539Q40345575-E259EB21-26B4-4BE8-97B1-3D3D5873AF0BQ40372680-119ACD24-585D-40B0-A9DE-C5E02EF4F331Q40446769-F2B2C709-2BBD-4CCF-9E83-3121024C1F4CQ41080636-EAC081CB-F8B5-43EF-B307-1901971A13DCQ41474751-F0C1FCD6-164D-47AC-9A24-2F6CEFF7EADDQ42220626-96D0611F-49EA-4315-A4E5-9879F5771556Q42966793-7F162A47-C257-4F39-B69F-76F0A8F015EAQ42989760-CEB8F764-C140-4361-9F39-FD0B78FD8B49Q42993921-66897112-20BD-4FCA-B81B-69FE008E3E4BQ44052396-63BB2E23-FF09-4B0D-8AE2-E26681BCF607Q44309802-22A0D889-B315-460E-9805-3CCE03FE5C01Q44862538-FEAB0903-3067-4BDA-94DA-FD2F3A1BA28BQ45240435-006A7E91-7DBD-4D8B-BC5D-33E2ED7933B3Q45408561-7808DB5F-64FD-4B4B-BE05-3898D465C3E0Q45534503-DAF1F4EE-E375-4C00-A9D7-0CB3F5FB4291Q45710827-048A9B1C-0B68-402F-8766-FFFFE3951E7BQ45945768-B0420B4F-4633-4E6A-A75D-E02476E127DBQ46328355-A94F2AE7-FE19-44AF-9E0B-3CB2F2435BE5Q46623464-E0322047-B74F-4596-A70D-935C13272AFBQ50593538-29739756-9F9E-4562-A225-852F9AE4245DQ50786968-49953738-16F0-456C-AF86-CA422A0E28D1Q50849790-F9E6ABD9-7D0E-48CA-AC45-9989C1EF845CQ50860685-B39FF26F-716D-4363-98E5-EC4EFF48AA21
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Maria E Tosti
@es
Maria E Tosti
@nl
Maria E Tosti
@sl
Maria E. Tosti
@en
type
label
Maria E Tosti
@es
Maria E Tosti
@nl
Maria E Tosti
@sl
Maria E. Tosti
@en
prefLabel
Maria E Tosti
@es
Maria E Tosti
@nl
Maria E Tosti
@sl
Maria E. Tosti
@en
P106
P1153
13105377700
P21
P31
P496
0000-0003-1392-9874